# L.A.M. Pharmaceutical, Corp.

- Location (FDA's records): Petaluma, CA
- FDA decisions: 1 (2002–2002): 1 510(k) clearance
- Product codes: MGQ (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 4 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Fidia Pharmaceutical Corp.: 1 (https://510kreport.com/company/fidia-pharmaceutical)
- Convatec, A Division of E.R. Squibb & Sons: 1 (https://510kreport.com/company/convatec-a-division-of-er-squibb-sons)

## Firms that cite its devices most
- Glycobiosciences, Inc.: 3 (https://510kreport.com/company/glycobiosciences)
- Oculus Innovative Sciences: 1 (https://510kreport.com/company/oculus-innovative-sciences)

## Its most-cited devices
- K020325: L.a.M. Ipm Wound Gel (2002), cited by 4

## Recent decisions
- K020325: L.a.M. Ipm Wound Gel (Apr 15, 2002)

Source page: https://510kreport.com/company/lam-pharmaceutical